Clinical Trials Browser

Phase 1/2 × Liver Neoplasms × apatinib × Clear all

NCT02727309 2016-04-04

A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms